Cargando…
Shengmai Injection Suppresses Angiotensin II-Induced Cardiomyocyte Hypertrophy and Apoptosis via Activation of the AMPK Signaling Pathway Through Energy-Dependent Mechanisms
Shengmai injection (SMI), a traditional Chinese herbal medicine extracted from Panax ginseng C.A. Mey., Ophiopogon japonicus (Thunb.) Ker Gawl., and Schisandra chinensis (Turcz.) Baill., has been used to treat acute and chronic heart failure. This study aimed to further clarify the effects of SMI on...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764192/ https://www.ncbi.nlm.nih.gov/pubmed/31616303 http://dx.doi.org/10.3389/fphar.2019.01095 |
_version_ | 1783454327760748544 |
---|---|
author | Li, Yiping Ruan, Xiaofen Xu, Xiaowen Li, Cha Qiang, Tingting Zhou, Hua Gao, Junjie Wang, Xiaolong |
author_facet | Li, Yiping Ruan, Xiaofen Xu, Xiaowen Li, Cha Qiang, Tingting Zhou, Hua Gao, Junjie Wang, Xiaolong |
author_sort | Li, Yiping |
collection | PubMed |
description | Shengmai injection (SMI), a traditional Chinese herbal medicine extracted from Panax ginseng C.A. Mey., Ophiopogon japonicus (Thunb.) Ker Gawl., and Schisandra chinensis (Turcz.) Baill., has been used to treat acute and chronic heart failure. This study aimed to further clarify the effects of SMI on energy metabolism. SMI could improve cell-survival rate and also reduce myocardial cell hypertrophy and apoptosis. Mitochondria are important sites of cellular energy metabolism, and SMI protects mitochondrial function which was evaluated by mitochondrial ultrastructure, mitochondrial respiratory control ratio (RCR), and mitochondrial membrane potential (ΔΨm) in this study. The expression levels of adenosine triphosphate (ATP), adenosine diphosphate (ADP), and phosphocreatine (PCr) increased. The expression levels of free fatty acid oxidation [carnitine palmitoyltransferase-1 (CPT-1)], glucose oxidation [glucose transporter-4 (GLUT-4)], and mitochondrial biogenesis-related genes (peroxisome proliferator-activated receptor-γ coactivator-1α [PGC-1α]) were upregulated after SMI treatment. AMP-activated protein kinase (AMPK) is an important signaling pathway regulating energy metabolism and also can regulate the above-mentioned indicators. In the present study, SMI was found to promote phosphorylation of AMPK. However, the effects of SMI on fatty acid, glucose oxidation, mitochondrial biogenesis, as well as inhibiting apoptosis of hypertrophic cardiomyocytes were partly blocked by AMPK inhibitor–compound C. Moreover, decreased myocardial hypertrophy and apoptosis treated by SMI were inhibited by AMPK knockdown with shAMPK to a certain degree and AMPK knockdown almost abolished the SMI-induced increase in the expression of GLUT-4, CPT-1, and PGC-1α. These data suggest that SMI suppressed Ang II–induced cardiomyocyte hypertrophy and apoptosis via activation of the AMPK signaling pathway through energy-dependent mechanisms. |
format | Online Article Text |
id | pubmed-6764192 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-67641922019-10-15 Shengmai Injection Suppresses Angiotensin II-Induced Cardiomyocyte Hypertrophy and Apoptosis via Activation of the AMPK Signaling Pathway Through Energy-Dependent Mechanisms Li, Yiping Ruan, Xiaofen Xu, Xiaowen Li, Cha Qiang, Tingting Zhou, Hua Gao, Junjie Wang, Xiaolong Front Pharmacol Pharmacology Shengmai injection (SMI), a traditional Chinese herbal medicine extracted from Panax ginseng C.A. Mey., Ophiopogon japonicus (Thunb.) Ker Gawl., and Schisandra chinensis (Turcz.) Baill., has been used to treat acute and chronic heart failure. This study aimed to further clarify the effects of SMI on energy metabolism. SMI could improve cell-survival rate and also reduce myocardial cell hypertrophy and apoptosis. Mitochondria are important sites of cellular energy metabolism, and SMI protects mitochondrial function which was evaluated by mitochondrial ultrastructure, mitochondrial respiratory control ratio (RCR), and mitochondrial membrane potential (ΔΨm) in this study. The expression levels of adenosine triphosphate (ATP), adenosine diphosphate (ADP), and phosphocreatine (PCr) increased. The expression levels of free fatty acid oxidation [carnitine palmitoyltransferase-1 (CPT-1)], glucose oxidation [glucose transporter-4 (GLUT-4)], and mitochondrial biogenesis-related genes (peroxisome proliferator-activated receptor-γ coactivator-1α [PGC-1α]) were upregulated after SMI treatment. AMP-activated protein kinase (AMPK) is an important signaling pathway regulating energy metabolism and also can regulate the above-mentioned indicators. In the present study, SMI was found to promote phosphorylation of AMPK. However, the effects of SMI on fatty acid, glucose oxidation, mitochondrial biogenesis, as well as inhibiting apoptosis of hypertrophic cardiomyocytes were partly blocked by AMPK inhibitor–compound C. Moreover, decreased myocardial hypertrophy and apoptosis treated by SMI were inhibited by AMPK knockdown with shAMPK to a certain degree and AMPK knockdown almost abolished the SMI-induced increase in the expression of GLUT-4, CPT-1, and PGC-1α. These data suggest that SMI suppressed Ang II–induced cardiomyocyte hypertrophy and apoptosis via activation of the AMPK signaling pathway through energy-dependent mechanisms. Frontiers Media S.A. 2019-09-20 /pmc/articles/PMC6764192/ /pubmed/31616303 http://dx.doi.org/10.3389/fphar.2019.01095 Text en Copyright © 2019 Li, Ruan, Xu, Li, Qiang, Zhou, Gao and Wang http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Li, Yiping Ruan, Xiaofen Xu, Xiaowen Li, Cha Qiang, Tingting Zhou, Hua Gao, Junjie Wang, Xiaolong Shengmai Injection Suppresses Angiotensin II-Induced Cardiomyocyte Hypertrophy and Apoptosis via Activation of the AMPK Signaling Pathway Through Energy-Dependent Mechanisms |
title | Shengmai Injection Suppresses Angiotensin II-Induced Cardiomyocyte Hypertrophy and Apoptosis via Activation of the AMPK Signaling Pathway Through Energy-Dependent Mechanisms |
title_full | Shengmai Injection Suppresses Angiotensin II-Induced Cardiomyocyte Hypertrophy and Apoptosis via Activation of the AMPK Signaling Pathway Through Energy-Dependent Mechanisms |
title_fullStr | Shengmai Injection Suppresses Angiotensin II-Induced Cardiomyocyte Hypertrophy and Apoptosis via Activation of the AMPK Signaling Pathway Through Energy-Dependent Mechanisms |
title_full_unstemmed | Shengmai Injection Suppresses Angiotensin II-Induced Cardiomyocyte Hypertrophy and Apoptosis via Activation of the AMPK Signaling Pathway Through Energy-Dependent Mechanisms |
title_short | Shengmai Injection Suppresses Angiotensin II-Induced Cardiomyocyte Hypertrophy and Apoptosis via Activation of the AMPK Signaling Pathway Through Energy-Dependent Mechanisms |
title_sort | shengmai injection suppresses angiotensin ii-induced cardiomyocyte hypertrophy and apoptosis via activation of the ampk signaling pathway through energy-dependent mechanisms |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764192/ https://www.ncbi.nlm.nih.gov/pubmed/31616303 http://dx.doi.org/10.3389/fphar.2019.01095 |
work_keys_str_mv | AT liyiping shengmaiinjectionsuppressesangiotensiniiinducedcardiomyocytehypertrophyandapoptosisviaactivationoftheampksignalingpathwaythroughenergydependentmechanisms AT ruanxiaofen shengmaiinjectionsuppressesangiotensiniiinducedcardiomyocytehypertrophyandapoptosisviaactivationoftheampksignalingpathwaythroughenergydependentmechanisms AT xuxiaowen shengmaiinjectionsuppressesangiotensiniiinducedcardiomyocytehypertrophyandapoptosisviaactivationoftheampksignalingpathwaythroughenergydependentmechanisms AT licha shengmaiinjectionsuppressesangiotensiniiinducedcardiomyocytehypertrophyandapoptosisviaactivationoftheampksignalingpathwaythroughenergydependentmechanisms AT qiangtingting shengmaiinjectionsuppressesangiotensiniiinducedcardiomyocytehypertrophyandapoptosisviaactivationoftheampksignalingpathwaythroughenergydependentmechanisms AT zhouhua shengmaiinjectionsuppressesangiotensiniiinducedcardiomyocytehypertrophyandapoptosisviaactivationoftheampksignalingpathwaythroughenergydependentmechanisms AT gaojunjie shengmaiinjectionsuppressesangiotensiniiinducedcardiomyocytehypertrophyandapoptosisviaactivationoftheampksignalingpathwaythroughenergydependentmechanisms AT wangxiaolong shengmaiinjectionsuppressesangiotensiniiinducedcardiomyocytehypertrophyandapoptosisviaactivationoftheampksignalingpathwaythroughenergydependentmechanisms |